Radcliffe CKM

💫 If obesity and #CKM overlap in your daily practice then New Horizons in Obesity Management is made for you 👉 ow.ly/cwMh50YTaNt 🗓️ Returning on Wednesday 17 June 2026, this one-day event brings together global leaders to explore shared disease pathways and personalised treatment strategies.

📚 Latest News : "Tirzepatide Linked to Lower Cardiorenal Events vs Dulaglutide" 🔓Access it here 👉 ow.ly/XZ4w106xMXt

📚 Latest News : "SOUL: Oral Semaglutide Improves CV Risk Factors in T2D" 🔓Access it here 👉 ow.ly/O01l106xAAa

✨The full e-SPACE CRM 2026 programme is now available on demand! Gain insights from global leaders in cardiology, nephrology, diabetology and obesity management. Watch expert-led #CRM sessions for free! 🔗 Access Here 👉 espace-crm.org/2026/v/s-39879… #CardioRenalMetabolic #CKM #Cardiology

📚 Latest News : "Ez-PAVE: Lower LDL-C Target Reduces CV Events" 🔓Access it here 👉 ow.ly/AfAw106xkYC

📚 Latest News : "hsCRP Improves CV Risk Prediction in Primary Prevention" 🔓Access it here 👉 ow.ly/XCAy106xi0J

🔴 Day Two Is Live Now! Join your peers and 60+ leading experts at e-SPACE CRM 2026 – your final chance to be part of this free, global and CME-accredited virtual event. 🔗 Join live: ow.ly/38rX50YGX5O #CardioRenalMetabolic #CKM #HeartFailure #KidneyHealth

🚨 Day Two Is About To Begin e-SPACE Cardio-Renal-Metabolic 2026 continues shortly. There’s still time to join. Today’s programme explores obesity as a central driver in CRM, key biomarkers, and combination therapy strategies shaping clinical practice. 🔗 Register now: ow.ly/gH6650YGWfi #CardioRenalMetabolic #CKM #Cardiology

✅ And that's a wrap for Day One of e-SPACE CRM 2026! We want to say a huge thank you to the Course Directors Christoph Wanner and Shalley Zieroth, the faculty whose expertise made this programme possible, and Translational Medicine Academy for their valued collaboration. 🔗 We hope you can join us tomorrow at 10:00 BST: ow.ly/lrsX50YGVNX #CardioRenalMetabolic #CKM #Cardiology

🔴 Day One of e-SPACE Is Live! ow.ly/zRHk50YGGfA Join now to access today’s key sessions: • Optimising outcomes in CKM disease • Evolving guidelines across cardiology, nephrology and diabetes • SGLT2 inhibitors, MRAs and GLP1 RAs in practice • HFpEF insights and emerging therapies #CardioRenalMetabolic #CKM #HeartFailure #DiabetesCare #KidneyHealth

🚨 We’re About To Begin e-SPACE Cardio-Renal-Metabolic 2026 goes live shortly. There’s still time to join. 🔗 Register now: espace-crm.org/2026?utm_sourc… Explore the intersection of cardiovascular disease, diabetes and chronic kidney disease through expert-led sessions, live panels and practical discussion. Join a global faculty tackling real-world CKM challenges. #CardioRenalMetabolic #CKM #Cardiology

Are you ready for e-SPACE CRM 2026? 💫 The sixth edition of e-SPACE CRM is just days away. Taking place this Friday, now is the time to secure your place and join a global community of clinicians focused on improving CRM care 🔗 ow.ly/g5Pk50YF2Xi #eSPACECRM26 #CRM #CVRM

✨ Obesity isn’t just a risk factor; it’s a driver of cardio-kidney-metabolic disease. Join global leaders on 17 June 2026 for New Horizons in Obesity Management to explore how modern therapies can modify disease progression, not just weight, and how to apply this in real-world practice 🔗 ow.ly/YzWi50YCnHQ #NHOM2026 #CKM

💫 New from ACC 2026 ➡️ updated recommendations on the evolving role of EPA, fibrates and N-3 fatty acids for cardiovascular prevention strategies: radcliffecvrm.com/video-index/ac… Explore how these updates apply to high- and very high-risk patients and how they align with existing guidance. This programme is supported by an unrestricted educational grant from Amarin.

We have more evidence in cardio-renal-metabolic medicine than ever before. Yet patients are still falling through the gaps between specialties. Data alone doesn’t change practice. e-Space CRM is where adoption actually happens! ✅ Free & virtual, live on 10–11 April 2026. Register here: ow.ly/NBvu50YBeqO #eSPACECRM26 #CRM #CVRM

📚 Latest News : "SOUL: Oral Semaglutide Aids CV Risk in T2D" 🔓Access it here 👉 ow.ly/pvTV106wt46

📚 Latest News : "GLP-1RAs Cut Cardiorenal Events in Type 1 Diabetes" 📚 New study: GLP-1RAs show cardiorenal benefits in type 1 diabetes, reducing the risk of MACEs, ESKD, and heart failure hospitalisation without increasing safety concerns. 👉 ow.ly/vy19106wr4x

📚 CKM conditions don’t exist in silos, so why do our guidelines? Join Christoph Wanner, Shelley Zieroth and 40+ global experts as they unpack the latest updates across diabetes, kidney, cardiovascular, and metabolic care, and make the case for simpler, unified guidance. Discover how aligning recommendations can cut complexity, close care gaps, and drive better outcomes across the CKM spectrum 🔗 ow.ly/a2Cn50YxWZi

📚 Latest News : "Aldosteronism Linked to AF and Stroke Risk in Older Adults" 📚 A higher aldosterone-renin ratio may increase the risk of atrial fibrillation and ischaemic stroke in older adults, a new cohort study analysis suggests. 👉 ow.ly/Feyx106w69C

✨ At New Horizons in Obesity Management 2026, the agenda is shaped by course directors Angela Fitch, Nikolaus Marx and Richard Hobbs ✨ ➡️ Swipe for more on the faculty leading this year’s programme. New for 2026, parallel track sessions will support more tailored learning across clinical settings and disease stages. We look forward to welcoming you to this year's event on 17 June 2026 🔗 ow.ly/yrWJ50Ywn34